Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Spokane › NPI 1609502350
Agency

Ortc, LLC

Ortc, LLC was paid $3.43M by Medicaid between Nov 2022 and Dec 2024, across 12 billing codes. Its largest line is H0020, Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) — 81% of everything it billed.

33Billing provider infoORTC, LLC
SPOKANE, WA 99208
33aNPI1609502350assigned 07/26/2022
33bProvider typeCase Management Agency
28Total paid$3.43M
24GClaims66,472
24DCodes billed12
24AFirst – last monthNov 2022 – Dec 2024
Compared with peers

Next to other Case Management Agency providers in Washington

Rank by total paid#18 of 129
Median peer was paid$423K
This provider vs. median8.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2022608$33K
202324,521$1.09M
2024incomplete41,343$2.30M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
H0020 Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) 81% 54,107 4,758 $2.78M
H0004 Behavioral health counseling and therapy, per 15 minutes 7.0% 4,257 3,021 $240K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 5.6% 1,864 1,484 $191K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3.9% 2,197 1,702 $133K
H0001 Alcohol and/or drug assessment 1.4% 359 353 $49K
81025 <1% 1,387 849 $10K
80305 <1% 1,028 702 $10K
93000 <1% 529 518 $4K
96164 <1% 212 211 $4K
86580 <1% 394 386 $2K
96165 <1% 122 122 $2K
G1028 Take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure <1% 16 16 $2K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHARRIS, MICHAEL (MANAGING MEMBER)
Parent organizationORTC, LLC
Same official

Other billing entities under HARRIS, MICHAEL

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.